Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Lung Diseases × demcizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Lung Diseases 1 Carcinoma 1

Interventions

Pemetrexed 3 Carboplatin 3 pralsetinib 2 pembrolizumab 2 sotorasib 1 sitravatinib 1 selpercatinib 1 patritumab 1 osimertinib 1 demcizumab 1 cobimetinib 1 atezolizumab 1 aflibercept 1 Tyrosine Kinase Inhibitors 1 Paclitaxel 1 Nivolumab 1 Ipilimumab 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Dasatinib 1 Cisplatin 1 Bevacizumab 1 Afatinib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02259582 2020-09-09

DENALI

Mereo BioPharma

Phase 2 Completed

82 enrolled 10 charts

Carcinoma, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡